title: Infrarenal aortic stenosis: long-term clinical and hemodynamic results of percutaneous transluminal angioplasty.
abstract: OBJECTIVE
  To evaluate the safety and long-term clinical and hemodynamic results of percutaneous transluminal angioplasty (PTA) of the infrarenal aorta.
  
  
  METHODS
  During nearly 10 years, 102 patients with symptomatic infrarenal atherosclerotic aortic stenosis underwent PTA. Follow-up information was available in 92 patients (17 men, 75 women; mean age, 51.9 years). Stenosis involved the aortic bifurcation in 18 patients and only the infrarenal abdominal aorta in 74 patients. Technical success was defined as residual stenosis less than 50% or a pressure gradient less than 10 mm Hg after PTA. Clinical patency was defined as the absence or improvement of symptoms after PTA. Hemodynamic patency was defined as a normal Doppler waveform in the common femoral arteries, an ankle-brachial ratio greater than 0.95, or the absence of a thigh-brachial pressure gradient.
  
  
  RESULTS
  Technical success was achieved in 78 patients after PTA. After 10 years, primary clinical and hemodynamic patency rates were 72% and 46%, respectively. After a mean follow-up of 51 months, 15 of the 22 symptomatic recurrences were due to aortic restenosis; 11 of these were treated with repeated PTA with or without stent placement, and three eventually required aortic surgery. No morbidity was encountered.
  
  
  CONCLUSIONS
  Infrarenal aortic PTA proved to be safe and provided durable, long-term clinical improvement. In this group of relatively young patients, the clinical patency rate of PTA was equivalent to that of aortic surgery but with less morbidity.
authors.affiliation: Dept of Radiology, Univ of Montreal Medical Center, Quebec, Canada.
authors.forename: P
authors.initials: P
authors.lastname: Audet
authors.forename: E
authors.initials: E
authors.lastname: Therasse
authors.forename: V L
authors.initials: VL
authors.lastname: Oliva
authors.forename: G
authors.initials: G
authors.lastname: Soulez
authors.forename: G
authors.initials: G
authors.lastname: Côté
authors.forename: R
authors.initials: R
authors.lastname: Wistaff
authors.forename: P V
authors.initials: PV
authors.lastname: Nguyen
authors.forename: J F
authors.initials: JF
authors.lastname: Blair
authors.forename: B T
authors.initials: BT
authors.lastname: Bui
authors.forename: J R
authors.initials: JR
authors.lastname: Cusson
mesh_terms: D000800:Angioplasty, Balloon; D001012:Aorta, Abdominal; D001018:Aortic Diseases / Q000503:physiopathology / Q000628:therapy*; D001161:Arteriosclerosis / Q000503:physiopathology / Q000628:therapy*; D003251:Constriction, Pathologic / Q000503:physiopathology / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D014654:Vascular Patency